America’s Biggest Criminal Drug Dealers Go Free and Continue to Push Their Drugs that Destroy Lives

Two of America's largest criminal drug dealers recently reached a $10 billion settlement for their role in America's opioid crisis that has cost tens of thousands of deaths and countless lives destroyed for the past several years. As part of this settlement, nobody goes to prison, and these drug dealers get to keep pushing their harmful drugs. They even get to spread out their criminal payments over several years so they don't suffer any business loss. The CDC had originally issued stricter guidelines for prescribing opioids in an effort to reduce illegal use and addictions, but a couple of weeks ago they backtracked on those guidelines making it easier for doctors to continue prescribing opioids. Deaths resulting from prescription pharmaceutical drugs far exceed deaths due to illegal street drugs, and it is not even close. The "war on drugs" started during the 1970s has created several generations now of mind-controlled drug users who incorrectly believe that illegal drugs are dangerous, while their prescription drugs are safe. The most commonly used "illegal drug" used by millions of Americans today is cannabis, or marijuana. While cannabis use has increased in the U.S. for both recreational and medical reasons, the pharma-funded corporate media continues to demonize it, and for good reason. Marijuana is best known for its recreational use, but if you can bypass the corporate censorship that obviously sees marijuana as a threat to patented pharmaceutical drugs, you will learn that the therapeutic benefits to marijuana are absolutely amazing. And some doctors are actually using medical marijuana to get people off of deadly opioids. According to data retrieved from the FDA due to a Freedom of Information Act request, nobody has ever died as a result of using marijuana, making it one of the safest natural drugs available, in spite of what you may be hearing and reading from the pharma-controlled corporate media.

Big Pharma Investing $BILLIONS in Patented Marijuana Drugs while the Natural Plant Remains Illegal to Millions of Americans

While the U.S. Federal Government continues to classify the marijuana plant as an illegal drug as part of the "Controlled Substances Act," the FDA has now approved patented drugs derived from the plant for medical use. One marijuana FDA-approved pharmaceutical product is currently being used to treat children for epilepsy, and the FDA is expected to approve another marijuana-based drug soon for treating multiple sclerosis. According to Fierce Pharma, the company with the first FDA-approved marijuana drug is investing $100 million to grow more pot, although if you try to grow some for yourself, depending on which state you live in, you could be arrested, spend time in prison, and have your children removed from your custody. In Idaho, for example, a state where marijuana sales still remain illegal, the new Jazz Pharmaceutical marijuana drug for treating multiple sclerosis that the FDA is expected to approve soon, needed a special bill in Idaho, and law makers who are against families using the natural marijuana plant and are all too willing to medically kidnap their children if they dare to use it, all of a sudden are pro-marijuana because a pharmaceutical company now sells it, and the FDA approves it. So while Idaho Senator Scott Grow supports marijuana if it is approved by the FDA as a drug, if it is not, he wants those who use the natural plant to be treated like criminals "to protect Idaho families." And that pretty much summarizes those who oppose marijuana as a natural plant, which is mainly among "Conservative" lawmakers. Treat loving parents as criminals if they use the natural plant and then take their children away from them, but treat the criminal FDA and Big Pharma as saints for providing marijuana patented drugs that can be prescribed by doctors. Meanwhile, a Bill to end the Federal ban on natural marijuana comes before the House this week. This is usually considered a "liberal Democratic" issue, as most Republican Conservatives support the "war on drugs" which is actually a war on natural herbal medicines which cannot be patented, in most cases, to protect the pharmaceutical industry. With Democrats in control of the House and Senate, as well as the White House, does this bill have a chance? Or will the pharmaceutical lobby make sure it never sees the light of day, as it has done for past many decades?

Medical Cannabis Gets Green-Light for Autism Treatment and Research

In January 2016, Hillary Clinton unveiled an autism initiative that was focused on bringing greater awareness to the epidemic. Clinton, who has received more pharmaceutical industry money than any leading political figure in the United States, wants “to ensure that all children, and in particular children from underserved backgrounds, can get screened for autism.” Reading between the political red tape and double speak, Clinton and the pharmaceutical industry are looking to create a funnel to drive millions affected by the autism spectrum into the drug company’s arms. There is a lot of buzz these days coming from the political and medical hot potato that is medical cannabis (marijuana). Many states are wrestling with current legislation, desperate not to give full control of this plant’s healing powers over to the people without high taxes and tracking systems. Two major events have just occurred within the last week. First, Pennsylvania is moving to become the first state to list autism as a qualifying condition for medical marijuana. If Pennsylvania’s SB3 becomes law, it will legally protect doctors who want to prescribe medical marijuana. In addition, the law would give parents and their children access to a powerful medical tool that would be covered by insurance. The second major event that is currently in the works is the world’s first official crowdfunded medical marijuana study at Colorado State University. Headed by Thorsten Rudroff, director of Colorado State University’s (CSU) Integrative Neurophysiology Lab, the study aims to conduct tests on at least 20 MS patients in northern Colorado who already are using medical marijuana and compare them with members of a control group of the same size who do not.